NCT01112020

Components of Chlorhexidine Gluconate Dressing

Components & Tolerability of Chlorhexidine Gluconate Dressing Patch Compared to BioPatch & Tegaderm Chlorhexidine Gluconate Securement Dressing After Application to Healthy Subjects Over a 7-day Period

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: C. R. Bard · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine the contents of a chlorhexidine-containing dressing after use.

Detailed description

To characterize the chemical composition of the CHG (2% CHG) Catheter Dressing Patch as compared to Biopatch Protective Disk with CHG, and Tegaderm IV (intravenous) Securement Dressing over a wear period of 7 days.

Conditions

• Healthy

Interventions

Type	Name	Description
DEVICE	CHG Catheter Dressing Patch	2% CHG dressing applied to 7 sites
DEVICE	Biopatch	Biopatch applied to 7 sites
DEVICE	Tegaderm CHG	Tegaderm CHG IV Securement Dressing applied to 7 sites

Timeline

• Start date: 2010-04-01
• Primary completion: 2010-05-01
• Completion: 2010-05-01
• First posted: 2010-04-28
• Last updated: 2025-11-26

Locations

1 site across 1 country: United States